The stock price’s performance over the year has been unpredictable, resulting in a mix of pessimistic and optimistic outlooks among investors. The index has shown a price loss of -30.26% this year. Over the last six months, there has been a stronger performance of -19.70%. The price of KAPA fallen by 1.92% during the last 30 days period. For the last 5-days stocks have improved 15.04%.
52-week price history of KAPA Stock
The history of a stock’s 52-week high and low prices can provide important information about its current state and future potential. Kairos Pharma Ltd’s current trading price is -73.50% away from its 52-week high, while its distance from the 52-week low is 24.62%. The stock’s price range for this period has been between $0.85 and $4.00. The Healthcare sector company’s shares saw a trading volume of about 0.84 million for the day, which was lower than the average daily volume of 2.35 million over the last three months.
The Connection Between Financial Performance and Market Capitalization
Kairos Pharma Ltd (KAPA) has experienced a quarterly decline of -30.72% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 14.52M.
How Moving Averages and Trading Volume Data Work Together
Based on Barchart.com data, the company’s moving average over the 100-day period was 1.3929, with a change in price of -0.3100. Similarly, Kairos Pharma Ltd recorded 1,607,137 in trading volume during the last 100 days, posting a change of -22.63%.
KAPA’s Debt-to-Equity Ratio: A Comprehensive Review
A key metric for assessing a company’s financial well-being and market status is the debt-to-equity (D/E) ratio. This ratio is derived by dividing a company’s total liabilities by its shareholders’ equity, and it demonstrates the level of debt a company uses to support its assets relative to shareholder equity. At the time of writing, the total D/E ratio for KAPA stands at 0.04. Similarly, the long-term debt-to-equity ratio is also 0.00.
KAPA Stock Stochastic Average
As of today, the raw stochastic average of Kairos Pharma Ltd over the past 50 days is 19.58%. This is a decrease compared to the raw stochastic average of the last 20 days, which was recorded at 52.43%. Additionally, the Stochastic %K and %D values for the company were 34.44% and 24.66%, respectively, over the past 20 days.
